Antagonists of microRNA-29 for use in the prevention and treatment of aortic aneurysms
The present invention relates to the use of antagonists of the miR-29 family to prevent and/or treat aortic aneurysms and rupture of atherosclerotic plaques.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Acetylation: a Time-Keeper of glucocorticoid Sensitivity
Understanding the regulatory mechanism paves the way to enhance the effectiveness of anti-inflammatory therapies and to develop strategies to counteract the negative effects of stress- and age-related cortisol excess. The…
Mini satellite wants to take quantum communication to space
Researchers from Jena, Würzburg and Potsdam have successfully developed a design for the smallest system of its kind so far to take highly secure quantum communication to space: Led by…
Results for control of pollutants in water
Brazilian scientists tested a simple and sustainable method for monitoring and degrading a mixture of polycyclic aromatic hydrocarbons, compounds present in fossil fuels and industrial waste. An article published in the journal Catalysis…